Stellar Pharmaceuticals Inc.
TSX VENTURE : SLX
OTC Bulletin Board : SLXCF

Stellar Pharmaceuticals Inc.

November 11, 2005 15:39 ET

Stellar Re-files Annual and Interim CEO and CFO Certifications

LONDON, ONTARIO--(CCNMatthews - Nov. 11, 2005) - Stellar Pharmaceuticals Inc., (OTCBB:SLXCF)(TSX VENTURE:SLX), Stellar Pharmaceuticals Inc. ("Stellar") announced that, at the request of the Ontario Securities Commission, it has re-filed its CEO and CFO financial statement certifications for the year ended December 31, 2004 and for the interim periods ended March 31, 2004, June 30, 2004, September 30, 2004, March 31, 2005 and June 30, 2005. Stellar had previously filed the U.S. equivalents of these certificates at the time the foregoing financial statements were filed with the Ontario Securities Commission. However, due to the fact that Stellar filed U.S. GAAP financial statements with the Securities and Exchange Commission rather than Canadian GAAP financial statements, the Canadian forms of certification should have been filed in place of the U.S. certificates.


The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • Stellar Pharmaceuticals Inc.
    Peter Riehl
    President & CEO
    (519) 434-1540 or (800) 639-0643
    or
    Stellar Pharmaceuticals Inc.
    Arnold Tenney
    Cell (416) 587-3200
    or
    INVESTOR RELATIONS COUNSEL:
    The Equity Group Inc.
    Devin Sullivan
    (212) 836-9608
    dsullivan@equityny.com
    or
    The Equity Group Inc.
    Adam Prior
    (212) 836-9606
    aprior@equityny.com